OMGA
Omega Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website omegatherapeutics.com
- Employees(FY) 116
- ISIN US68217N1054
Performance
0.0%
1W
-13.8%
1M
-48.08%
3M
-24.54%
6M
-32.56%
YTD
-75.36%
1Y
Profile
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Technical Analysis of OMGA 2024-05-31
Overview:
In analyzing the technical indicators for OMGA stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming trading ...
Recent News & Updates
- 2024-06-11 19:00
- 2024-05-29 19:00
- 2024-05-28 19:00
- 2024-05-08 19:00
- 2024-05-07 19:00
- 2024-05-06 02:52
- 2024-05-05 20:10
- 2024-05-05 19:00
- 2024-04-24 22:02
- 2024-04-22 19:00
- 2024-04-16 21:55
- 2024-04-08 19:00
- 2024-04-07 20:00
- 2024-04-03 00:00
- 2024-03-28 11:54
- 2024-03-27 22:25
- 2024-03-27 21:15
- 2024-03-18 20:30
- 2024-03-05 18:00
- 2024-01-09 10:01
The 3 Best Biotech Stocks to Buy in January 2024(Yahoo Finance)
- 2024-01-08 19:44
- 2024-01-07 17:30
- 2024-01-07 17:30
- 2024-01-04 23:55
Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk(Yahoo Finance)
- 2024-01-04 05:08
Why Novo Nordisk Stock Crushed the Market Today(Yahoo Finance)
- 2024-01-04 03:01
- 2024-01-03 21:02
Novo Nordisk enters research partnerships with biotech firms(Yahoo Finance)
- 2024-01-03 19:20
Why Is Omega Therapeutics (OMGA) Stock Up 111% Today?(Investorplace)
- 2024-01-03 17:00
- 2024-01-03 16:59
Page 1 of 4
previousnext